Published in Nat Genet on April 01, 1995
Gene Therapy for Wiskott-Aldrich Syndrome (TIGET-WAS) | NCT01515462
Cdc42: An essential Rho-type GTPase controlling eukaryotic cell polarity. Microbiol Mol Biol Rev (1999) 3.61
Disorders of lysosome-related organelle biogenesis: clinical and molecular genetics. Annu Rev Genomics Hum Genet (2008) 2.83
Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest (1996) 1.87
Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev (2012) 1.61
Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains. Mol Biol Cell (1998) 1.38
Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol (2012) 1.27
Genetics of familial forms of thrombocytopenia. Hum Genet (2012) 1.24
X-Linked syndrome of polyendocrinopathy, immune dysfunction, and diarrhea maps to Xp11.23-Xq13.3. Am J Hum Genet (2000) 1.22
Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans. J Autoimmun (2013) 1.07
Warts and all: human papillomavirus in primary immunodeficiencies. J Allergy Clin Immunol (2012) 1.06
Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state. Blood (2010) 1.00
An autosomal dominant thrombocytopenia gene maps to chromosomal region 10p. Am J Hum Genet (1999) 0.98
miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis. Elife (2014) 0.94
Inherited platelet disorders: thrombocytopenias and thrombocytopathies. Blood Transfus (2009) 0.89
Structure-function analysis of the WIP role in T cell receptor-stimulated NFAT activation: evidence that WIP-WASP dissociation is not required and that the WIP NH2 terminus is inhibitory. J Biol Chem (2007) 0.88
Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia. Blood (2015) 0.86
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment. Immunol Allergy Clin North Am (2010) 0.85
A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding. J Allergy Clin Immunol (2011) 0.84
An update on the use of immunoglobulin for the treatment of immunodeficiency disorders. Immunotherapy (2014) 0.83
Genetic predispositions to childhood leukemia. Ther Adv Hematol (2013) 0.82
The Wiskott-Aldrich syndrome. Clin Exp Immunol (2000) 0.82
Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies. Clin Mol Allergy (2011) 0.81
Novel anti-HIV therapeutics targeting chemokine receptors and actin regulatory pathways. Immunol Rev (2013) 0.80
SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells. Blood (2015) 0.79
The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review. Allergy Asthma Clin Immunol (2010) 0.79
Immunogenetics: changing the face of immunodeficiency. J Clin Pathol (2000) 0.79
A familial case of Wiskott-Aldrich Syndrome with a hotspot mutation in exon 2 of the WAS Gene. J Korean Med Sci (2007) 0.79
Diffuse large B cell lymphoma in wiskott-Aldrich syndrome: a case report and review of literature. Indian J Hematol Blood Transfus (2014) 0.78
Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease. Nat Commun (2017) 0.78
Wiskott-Aldrich syndrome proteins in the nucleus: aWASH with possibilities. Nucleus (2015) 0.78
Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome. Blood (2014) 0.78
Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. J Clin Immunol (2013) 0.77
Wiskott-Aldrich syndrome: another piece in the puzzle. Clin Exp Immunol (2005) 0.76
Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene. J Clin Immunol (2014) 0.76
Development of central nervous system autoimmunity is impaired in the absence of Wiskott-Aldrich syndrome protein. PLoS One (2014) 0.75
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency. Sci Rep (2017) 0.75
Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia. J Clin Immunol (2013) 0.75
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature (1998) 4.47
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature (1995) 2.93
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood (2001) 2.50
Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression. Blood (1999) 2.07
Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol (1997) 1.52
Pyrimidine 5'-nucleotidase acquired deficiency in beta-thalassemia: involvement of enzyme-SH groups in the inactivation process. Acta Haematol (1989) 1.39
In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet (1996) 1.35
Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood (1997) 1.34
Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)". Immunol Rev (1994) 1.32
Early and multifocal tumors in breast, salivary, harderian and epididymal tissues developed in MMTY-Neu transgenic mice. Cancer Lett (1992) 1.32
Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood (1997) 1.23
Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet (1997) 1.20
Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family. J Clin Pathol (2006) 1.15
Predominance of 'memory' phenotype within CD4+ and CD8+ lymphocyte subsets after allogeneic BMT. Bone Marrow Transplant (1993) 1.11
Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood (1997) 1.10
Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet (2001) 1.05
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol Life Sci (2006) 1.04
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood (2000) 1.03
The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlates. Brain (1998) 1.03
Anaphylaxis in children: clinical and allergologic features. Pediatrics (1998) 1.01
Gastrointestinal symptoms in atopic eczema. Arch Dis Child (1998) 1.00
First polar body morphology before ICSI is not related to embryo quality or pregnancy rate. Hum Reprod (2004) 0.98
Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci U S A (1994) 0.98
Performance of a component-based allergen-microarray in the diagnosis of cow's milk and hen's egg allergy. Clin Exp Allergy (2010) 0.98
Assessment of the role of genetic polymorphism in venous thrombosis through artificial neural networks. Ann Hum Genet (2005) 0.96
Immunodeficiencies. Clin Exp Immunol (2009) 0.96
Identification of microdeletions spanning the Diamond-Blackfan anemia locus on 19q13 and evidence for genetic heterogeneity. Am J Hum Genet (1998) 0.96
Clinical, biochemical and molecular findings in a series of families with hereditary hyperferritinaemia-cataract syndrome. Br J Haematol (2001) 0.96
DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement Geriatr Cogn Disord (1998) 0.96
Double blind, placebo controlled study of nedocromil sodium in asthma. Arch Dis Child (1993) 0.95
Comparison of endothelial function evaluated by strain gauge plethysmography and brachial artery ultrasound. Atherosclerosis (2001) 0.95
Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer. Reprod Biomed Online (2008) 0.95
Mutations of the Fanconi anemia group A gene (FAA) in Italian patients. Am J Hum Genet (1997) 0.93
Determination of allergenicity to three cow's milk hydrolysates and an amino acid-derived formula in children with cow's milk allergy. Clin Exp Allergy (2002) 0.93
Stem cell transplantation for primary immunodeficiencies. Bone Marrow Transplant (2008) 0.93
Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol (1992) 0.92
Defective function of Fas in patients with type 1 diabetes associated with other autoimmune diseases. Diabetes (2001) 0.91
Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes. J Immunol (1993) 0.91
Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am J Hum Genet (1995) 0.90
Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome. Cancer Gene Ther (2000) 0.89
ZPLD1 gene is disrupted in a patient with balanced translocation that exhibits cerebral cavernous malformations. Neuroscience (2008) 0.89
Cross-reactivity between milk proteins from different animal species. Clin Exp Allergy (1999) 0.89
Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers. J Am Acad Dermatol (1996) 0.89
Stem cell factor suppresses apoptosis in neuroblastoma cell lines. Exp Hematol (1997) 0.88
Hematological studies in children with Down syndrome. Pediatr Hematol Oncol (1996) 0.87
[The value of the MR imaging in the evaluation of Müllerian duct anomalies]. Radiol Med (2001) 0.87
Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics (2000) 0.86
CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosis. Clin Rheumatol (1994) 0.86
Genomic organization of the human VP16 accessory protein, a housekeeping gene (HCFC1) mapping to Xq28. Genomics (1994) 0.86
Cell adhesion molecule expression in cord blood CD34+ cells. Stem Cells (1998) 0.85
The chromosome localization and the HCF repeats of the human host cell factor gene (HCFC1) are conserved in the mouse homologue. Genomics (1996) 0.85
Elimination diet and intestinal permeability in atopic eczema: a preliminary study. Clin Exp Allergy (1993) 0.85
An evaluation of the brachial plexus block at the humeral canal using a neurostimulator (1417 patients): the efficacy, safety, and predictive criteria of failure. Anesth Analg (2001) 0.84
Food related, exercise induced anaphylaxis. Arch Dis Child (1996) 0.84
Genetic fitness in Huntington's Disease and Spinocerebellar Ataxia 1: a population genetics model for CAG repeat expansions. Ann Hum Genet (1996) 0.84
Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides. Allergy (2002) 0.84
X-linked bulbar and spinal muscular atrophy, or Kennedy disease: clinical, neurophysiological, neuropathological, neuropsychological and molecular study of a large family. J Neurol Sci (1996) 0.84
Diamond-Blackfan Anaemia: an overview. Paediatr Drugs (2001) 0.84
Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci Lett (1995) 0.84
MicroRNA profiling as a tool for pathway analysis in a human in vitro model for neural development. Curr Med Chem (2012) 0.84
Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients. Lupus (2005) 0.83
Long-term bone marrow cultures in Diamond-Blackfan anemia reveal a defect of both granulomacrophage and erythroid progenitors. Exp Hematol (1999) 0.83
Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia. Blood Cancer J (2013) 0.83
Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy (2000) 0.83
Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss. AIDS Res Hum Retroviruses (1997) 0.83
The primary response to HIV infection is characterized by an expansion of activated CD8+ CD28- cells. AIDS (1996) 0.83
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins. Br J Rheumatol (1998) 0.83
Effects of toluene and benzene air mixtures on human lung cells (A549). Exp Toxicol Pathol (2008) 0.82
Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy. Cancer Gene Ther (2001) 0.82
C to T mutation causing premature termination of CD40 ligand at amino acid 221 in a patient affected by hyper IgM syndrome. Hum Mutat (1994) 0.82
Monoclonal expansion of large granular lymphocytes with a CD4+ CD8dim+/- phenotype associated with hairy cell leukemia. Haematologica (1995) 0.82
Clustering of distinct autoimmune diseases associated with functional abnormalities of T cell survival in children. Clin Exp Immunol (2000) 0.82
Androgen receptor gene (CAG)n repeat analysis in the differential diagnosis between Kennedy disease and other motoneuron disorders. Am J Med Genet (1995) 0.81
The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice. Breast Cancer Res Treat (1997) 0.81
Cell cycle analysis in the diagnosis of Fanconi's anemia. Haematologica (2000) 0.81
Anaphylaxis induced by exercise and related to multiple food intake. Allergy Asthma Proc (1997) 0.81
An optimized method for in vitro exposure of human derived lung cells to volatile chemicals. Exp Toxicol Pathol (2008) 0.81
Expansion of large granular lymphocyte subsets in Wiskott-Aldrich syndrome. Haematologica (1996) 0.81
Effect of stem cell factor on colony growth from acquired and constitutional (Fanconi) aplastic anemia. Blood (1992) 0.81
Local regression of breast tumors following intramammary ganciclovir administration in double transgenic mice expressing neu oncogene and herpes simplex virus thymidine kinase. Gene Ther (1995) 0.80
Genetic and cellular basis of cerebral cavernous malformations: implications for clinical management. Clin Genet (2012) 0.80
Atopy in children with otitis media with effusion. Clin Exp Allergy (1998) 0.80
Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene. Blood (1996) 0.80
The cell death-inducing ability of glycoprotein 120 from different HIV strains correlates with their ability to induce CD4 lateral association with CD95 on CD4+ T cells. AIDS Res Hum Retroviruses (1999) 0.80
Partial respecification of nasotemporal polarity in double-temporal chick and chimeric chick-quail eyes. Mech Dev (1998) 0.80
Human CD40L gene maps between DXS144E and DXS300 in Xq26. Genomics (1994) 0.80
Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus. Clin Rheumatol (1992) 0.80
CD134/OX40 expression by synovial fluid CD4+ T lymphocytes in chronic synovitis. Br J Rheumatol (1998) 0.80
Embryonic production of nitric oxide and its role in implantation: a pilot study. J Assist Reprod Genet (2003) 0.80